BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28487826)

  • 1. Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels.
    Donida B; Marchetti DP; Jacques CED; Ribas G; Deon M; Manini P; da Rosa HT; Moura DJ; Saffi J; Giugliani R; Vargas CR
    Mol Genet Metab Rep; 2017 Jun; 11():46-53. PubMed ID: 28487826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation.
    Jacques CE; Donida B; Mescka CP; Rodrigues DG; Marchetti DP; Bitencourt FH; Burin MG; de Souza CF; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2016 Sep; 1862(9):1608-16. PubMed ID: 27251652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory process and oxidative/nitrative stress: in vivo study in mucopolysaccharidosis type IV A patients under long-term enzyme replacement therapy.
    Aguilar Delgado C; Hammerschmidt T; Faverzini JL; Lopes F; Giugliani R; Baldo G; Vargas CR
    Arch Biochem Biophys; 2023 Mar; 737():109541. PubMed ID: 36754222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
    Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
    Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
    Ullal AJ; Millington DS; Bali DS
    Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
    Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
    Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
    Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
    Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
    Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
    Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.
    Shams S; Barazandeh Tehrani M; Civallero G; Minookherad K; Giugliani R; Setoodeh A; Haghi Ashtiani MT
    J Diabetes Metab Disord; 2017; 16():37. PubMed ID: 28904929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
    Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
    J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease.
    Fateen EM; El Mawgoud HA; Eissa NR; Ibrahim MM; Aglan MS; Essawi ML
    Gene; 2017 Feb; 600():48-54. PubMed ID: 27825773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
    Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
    Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
    Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voice alterations in patients with Morquio A syndrome.
    Szklanny K; Gubrynowicz R; Tylki-Szymańska A
    J Appl Genet; 2018 Feb; 59(1):73-80. PubMed ID: 29275451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.
    Chin SJ; Saville JT; McDermott BK; Zankl A; Fletcher JM; Fuller M
    JIMD Rep; 2020 Sep; 55(1):68-74. PubMed ID: 32905071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.